Forward Citations = 8

Loading Chart...

4 inventors (with patents filed for the assignee):

John Rothman (6 out of 23 patents)

William J Garner (6 out of 17 patents)

Amie Franklin (5 out of 5 patents)

4. Arnie Franklin (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 11147800 - Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof (2021-10-19),

2. 11135201 - Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof (2021-10-05),

3. 10548876 - Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof (2020-02-04),

4. 10500192 - Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof (2019-12-10),

5. 9993460 - Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof (2018-06-12),

6. 9974774 - Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof (2018-05-22),

Company Overview

Race Oncology Ltd. is a biotechnology company focused on the development of a drug called Bisantrene for the treatment of a rare type of leukemia known as acute myeloid leukemia (AML). Bisantrene has shown promising results in preclinical studies and is currently being evaluated in clinical trials. The company's mission is to bring this potentially life-saving treatment to patients in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#42 in Melbourne

#650 in Australia

Melbourne, Australia

Race Oncology Ltd.

Forward Citations = 8

4 inventors:

John Rothman (6 out of 23 patents)

William J Garner (6 out of 17 patents)

Amie Franklin (5 out of 5 patents)

4. Arnie Franklin (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Race Oncology Ltd.. Retrieved from https://idiyas.com/company/race-oncology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]